— Colgate-Palmolive Company (NYSE: CL) reported Q4 2019 earnings of $0.73 per share, vs. $0.73 expected.
— Sales grew 5.5% to $4 billion, vs. $3.9 billion expected.
— North America net sales increased 1.5%.
— Latin America net sales rose 2%.
— Europe net sales increased 10%.
— Asia-Pacific net sales grew 7%.
— Africa/Eurasia net sales increased 7.5%.
— Hill’s Pet Nutrition net sales rose 8%.
— FY2020 net sales is expected to grow 4-6% and organic sales is expected to grow 3-5%.
— For FY2020, the company expects a mid to high single digit increase in GAAP EPS and a low to mid single digit increase in adjusted EPS.
— CL shares were up 5% in premarket hours on Friday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
